PENTIXAPHARM HOLDING N AG (PTP) — Capital Reinvestment Ratio

Latest as of December 2023: 2.32x

PENTIXAPHARM HOLDING N AG (PTP) has a Capital Reinvestment Ratio of 2.32x as of December 2023, meaning it reinvests 2% of its operating cash flow (€2.13 Million) in capital expenditures (€4.94 Million). Check PTP tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.32x
Capex / Operating Cash Flow

Operating Cash Flow

€2.13 Million
EUR

Capital Expenditures

€4.94 Million
EUR

Data as of

Dec 2023
Most recent filing

PENTIXAPHARM HOLDING N AG Capital Reinvestment Ratio (2023–2023)

This chart tracks PENTIXAPHARM HOLDING N AG's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of PENTIXAPHARM HOLDING N AG.

Annual Capital Reinvestment Ratio for PENTIXAPHARM HOLDING N AG (2023–2023)

Year-by-year Capital Reinvestment Ratio for PENTIXAPHARM HOLDING N AG from 2023 to 2023. See PENTIXAPHARM HOLDING N AG (PTP) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2023 2.32x €2.13 Million €4.94 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow